NCT03097783View on ClinicalTrials.gov

Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency

NACompletedINTERVENTIONAL

Enrollment

169

Participants

Timeline

Start Date

April 26, 2017

Primary Completion Date

March 23, 2018

Study Completion Date

September 14, 2018

Conditions

Midface Volume Deficit

Interventions

DEVICE

Restylane Perlane Lidocaine

Intradermal injection

Trial Locations (1)

Unknown

Q-Med AB, Shanghai

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galderma R&D

INDUSTRY